Patients with different subtypes of metabolic syndrome experience varying prevalence rates of stroke and ischemic heart disease.

The Food and Drug Administration (FDA) has moved to restrict the sale of unapproved ingestible fluoride prescription drug products, stating that action will be taken against any company marketing the ...

Higher dietary fiber intake — especially from cereals and fruits — may reduce the risk of developing gout among women.

Primary OS analysis results from STELLAR-303 showed zanzalintinib + atezolizumab improved OS vs regorafenib in metastatic colorectal cancer.

The percentage of those with early-onset diverticulitis admitted for complicated diverticulitis went from 18.5% to 28.2% from 2005 to 2020.

Developers of biosimilars will no longer be required to conduct clinical trials to prove effectiveness for FDA approval.

Physicians with H-1B-sponsored visas accounted for 0.97% of physicians in the United States in fiscal year 2024.

Nearly two-thirds of asymptomatic adults in a US safety-net health care system tested positive for Helicobacter pylori antibodies.

Individuals with MetALD vs MASLD have significantly higher risks for liver-related events, liver cancer, and extrahepatic cancers.

The probability of developing ocular EIMs was comparable across treatment classes among patients with HLA-B27-associated diseases.

Moderate-to-vigorous physical activity guideline adherence was associated with a 22% and 17% lower CHD risk in women and men, respectively.

Ustekinumab and vedolizumab have comparable safety and efficacy in older and younger adults with IBD, indicating that age should not be a deterrent for treatment.